John Nosenzo - 10 Feb 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: CHIEF COMMERCIAL OFFICER
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 10 Feb 2022
Net transactions value: +$311,760
Form type: 4
Filing time: 14 Feb 2022, 19:41:58 UTC
Previous filing: 04 Jun 2021
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise		+66,139	+13228%		66,639	10 Feb 2022	Direct	F1
transaction	BVS	Class A Common Stock	Tax liability	$311,760	+24,205	+133%	$12.88	42,434	10 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Phantom Profit Units	Options Exercise	$0	-66,139	-100%	$0.000000^*	0	10 Feb 2022	Class A Common Stock	66,139		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Phantom Profit Unit represented a contingent right to receive one share of Class A common stock and vested on the one-year anniversary of the consummation of the Isuser's initial public offering.